FDA approves GSK's RSV vaccine for older adults, world's first shot against virus

The FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that targets respiratory syncytial virus to the market.

from Health and Science https://ift.tt/aZc0HLQ
https://ift.tt/xIdlkYA
https://ift.tt/1WmoJAL